Filter Results:
(3,165)
Show Results For
- All HBS Web
(3,165)
- People (10)
- News (983)
- Research (1,708)
- Events (6)
- Multimedia (34)
- Faculty Publications (703)
Show Results For
- All HBS Web
(3,165)
- People (10)
- News (983)
- Research (1,708)
- Events (6)
- Multimedia (34)
- Faculty Publications (703)
- February 2005 (Revised November 2012)
- Supplement
UAL 2004: Pulling Out of Bankruptcy (CW)
By: Daniel Baird Bergstresser, Kenneth A. Froot and Darren Robert Smart
UAL is a large air transportation company with roots that go back to the 1920s. As a legacy carrier, going back to before the 1978 deregulation of air transportation markets, United Airlines is burdened with cost structures that make it difficult to compete with newer... View Details
- November 2016
- Case
QuintilesIMS: Biosimilar Marketing in England
By: John A. Quelch and Emily C. Boudreau
QuintilesIMS was a leading healthcare consulting firm best known for its data and information offerings as well as its market research and management consulting services for life science companies. By 2015, the company was expanding beyond the biopharmaceutical... View Details
Keywords: Health; Pharmaceutical Industry; Biotech; Marketing; Health Care and Treatment; Biotechnology Industry; England
Quelch, John A., and Emily C. Boudreau. "QuintilesIMS: Biosimilar Marketing in England." Harvard Business School Case 517-054, November 2016.
- Web
Strategy for Health Care Delivery - Institute For Strategy And Competitiveness
organizational models for transforming the way health care is delivered, measured, and reimbursed. Empowered with new insights and capabilities, you will return to your organization prepared to implement and oversee a value-based View Details
- June 2021
- Article
Developing a Value Framework: Utilizing Administrative Data to Assess an Enhanced Care Initiative
By: Casey J. Allen, Jarrod S. Eska, Nikhil G. Thaker, Thomas W. Feeley, Robert S. Kaplan, Ryan W. Huey, Ching-Wei D. Tzeng, Jeffrey E. Lee, Steven J. Frank, Thomas A. Aloia, Vijaya Gottumukkala and Matthew H.G. Katz
We used national administrative data to assess multiple domains of value associated with enhanced recovery pathways for patients undergoing pancreatic surgery. Value metrics included in-hospital mortality, complication rates, length of stay (LOS), 30-day readmission... View Details
Keywords: Value-based Health Care; Health Care and Treatment; Analytics and Data Science; Outcome or Result; Measurement and Metrics; Performance Improvement
Allen, Casey J., Jarrod S. Eska, Nikhil G. Thaker, Thomas W. Feeley, Robert S. Kaplan, Ryan W. Huey, Ching-Wei D. Tzeng, Jeffrey E. Lee, Steven J. Frank, Thomas A. Aloia, Vijaya Gottumukkala, and Matthew H.G. Katz. "Developing a Value Framework: Utilizing Administrative Data to Assess an Enhanced Care Initiative." Journal of Surgical Research 262 (June 2021): 115–120.
- April 2014 (Revised January 2015)
- Background Note
Note on Mobile Healthcare
By: John A. Quelch and Margaret L. Rodriguez
Delivering health care to the global population was a challenge. Health care costs accounted for ten percent of world GDP by 2013. In the U.S., health care costs were expected to top $3.1 trillion in 2014. New technologies, shortages of trained personnel and... View Details
Keywords: Health Care; Mobile; Mobile App; Public Health; Startups; Hardware; Software; Telemedicine; Global; Medical Devices; Medical Services; Medical Solutions; Entrepreneurs; Government And Business; Technological Change; Health Care and Treatment; Entrepreneurship; Government and Politics; Technological Innovation; Applications and Software; Information Infrastructure; Health Industry; Health Industry
Quelch, John A., and Margaret L. Rodriguez. "Note on Mobile Healthcare." Harvard Business School Background Note 514-122, April 2014. (Revised January 2015.)
- Article
Drivers of the Variation in Prosthetic Implant Purchase Prices for Total Knee and Total Hip Arthroplasties
By: Derek A. Haas, Kevin J Bozic, Anthony M. DiGioia, Zirui Song and Robert S. Kaplan
Previous studies have documented wide variation in health-care spending and prices; however, the causes for the variation in supply purchase prices across providers are not well understood. The purpose of this study was to determine the drivers of variation in... View Details
Keywords: Costing; Cost Variation; Total Knee Arthroplasty; Total Hip Arthroplasty; Prosthetic Implant Cost; Health Care and Treatment; Cost Management; Health Industry; Health Industry
Haas, Derek A., Kevin J Bozic, Anthony M. DiGioia, Zirui Song, and Robert S. Kaplan. "Drivers of the Variation in Prosthetic Implant Purchase Prices for Total Knee and Total Hip Arthroplasties." Journal of Arthroplasty 32, no. 2 (February 2017): 347–350.
- October 10, 2019
- Article
The Case for the Public Option Over Medicare for All
By: Regina E. Herzlinger and Richard Boxer
How can the United States better control its health care costs and quality and still achieve universal coverage? The strongest choice is not Medicare for All, which would eliminate private insurance; it’s the public option, which would allow people to choose from... View Details
Keywords: Universal Health Coverage; Public Option; Medicare; Health Care and Treatment; Insurance; Cost Management; Quality; United States
Herzlinger, Regina E., and Richard Boxer. "The Case for the Public Option Over Medicare for All." Harvard Business Review Digital Articles (October 10, 2019): 2–5.
- 25 Jun 2018
- Blog Post
The Internship Search: “Is this just a personal interest, or is there a real professional opportunity here?”
marketing. And he wanted to test his interest in health and wellness. “Is this just a personal interest, or is there a real professional opportunity here?” Aaron asked himself. With an eye toward... View Details
Keywords: Consumer Products / Retail
- Research Summary
Clinical Trials as a setting for Health Policy and Management Research
The clinical trial marketplace is in flux. A decade ago, pharmaceutical firms almost exclusively conducted the study of their novel drug compounds within major academic medical centers. But today, industry-sponsored clinical trials are increasingly using community... View Details
- Web
Women, Work, and the “M” Word - Blog: Health Supplement
gives women more opportunities to take breaks when experiencing symptoms. An adequate number of sick days or mental health days is beneficial for scheduling doctor’s appointments. When in the office, unlimited bathroom breaks, resting... View Details
- Article
Healthy Buildings in 2070
By: John D. Macomber and Joseph G. Allen
Fifty years seems a very long time in the future for most industries. Not so in buildings and real estate; built structures routinely last decades if not hundreds of years, as long as they are economically competitive. Any discussion of the 50-year future has to... View Details
Keywords: Health & Wellness; Real Estate; Architectural Innovation; Public Health; Health; Buildings and Facilities; Well-being
Macomber, John D., and Joseph G. Allen. "Healthy Buildings in 2070." The Bridge 50, no. S (Winter 2020): 11–14. (Special 50th Anniversary Issue edited by Ronald M. Latanision.)
- 15 Feb 2022
- Blog Post
Health Is Wealth | The Path To Creating A Venture
opportunities to leverage technology to help people experience their healthcare in a better way. Driven by her own personal health experiences in where she constantly used a guess and check methodology to... View Details
- 02 Jan 2020
- Op-Ed
Medicare for All or Public Option: Can Either Heal Health Care?
The United States has serious health care problems: More than 27 million uninsured people, costs that are growing faster than income, and a staggering $37 trillion of unfunded liabilities in the Medicare... View Details
- Article
Ten Year Sunset Rule for Healthcare Regulation Is a Nonstarter and Discouragement to Post-COVID-19 Investment
By: Regina E. Herzlinger and Eugene Schneller
U.S. healthcare delivery has not benefitted from the same productivity growth as many other service industries, such as bricks and mortar retailing, a loss that has gravely diminished cost control and access. Regulatory capture, which creates barriers to venture... View Details
Keywords: Health Care; COVID-19; Regulation; Health Care and Treatment; Health Pandemics; Governing Rules, Regulations, and Reforms; Investment
Herzlinger, Regina E., and Eugene Schneller. "Ten Year Sunset Rule for Healthcare Regulation Is a Nonstarter and Discouragement to Post-COVID-19 Investment." Journal of Health Care Finance 47, no. 4 (Spring 2021). (Special Commentary.)
- 15 Feb 2022
- Blog Post
Health is Wealth | The Path to Creating a Venture
opportunities to leverage technology to help people experience their healthcare in a better way. Driven by her own personal health experiences in where she constantly used a guess and check methodology to... View Details
- June 2021
- Case
HelloSelf: Launch
By: John R. Wells and Benjamin Weinstock
In April 2021, Charles Wells, founder and CEO of HelloSelf was reflecting on the company’s progress since it launched two years earlier. HelloSelf’s goal was to help the mentally ill recover and those who were mentally fit to stay well and feel even better. To do this,... View Details
Keywords: Mental Health; Health Care and Treatment; Internet and the Web; Growth and Development Strategy; Great Britain
Wells, John R., and Benjamin Weinstock. "HelloSelf: Launch." Harvard Business School Case 721-432, June 2021.
- 17 Feb 2016
- Blog Post
Through The Eyes of The Patient: A Recap of The 13th Annual Health Care Conference
Over 650 people participated in the 13th annual Harvard Business School Health Care Club Conference, which took place on campus on Saturday, January 30th, 2016. The conference brought together students of business, medicine, government,... View Details
Keywords: Health Care
- 05 Dec 2013
- Op-Ed
Encourage Breakthrough Health Care by Competing on Products Rather Than Patents
Like many people interested in the tangled connections between health care progress and intellectual property rights, I avidly followed the Myriad Genetics case, decided by the Supreme Court this June 13. In sum, molecular diagnostics... View Details
- July 2020
- Article
Lessons from the Impact of Price Regulation on the Pricing of Anticancer Drugs in Germany
By: Victoria D. Lauenroth, Aaron S. Kesselheim, Ameet Sarpatwari and Ariel Dora Stern
Worldwide spending on prescription drugs has increased dramatically in recent years. Although this increase has been particularly pronounced in the U.S., it remains largely unaddressed there. In Europe, however, different approaches to regulating drug prices have been... View Details
Keywords: Pharmaceuticals; Prescription Drug Costs; Drug Pricing; Access To Care; Cost Reduction; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Cost Management; Germany
Lauenroth, Victoria D., Aaron S. Kesselheim, Ameet Sarpatwari, and Ariel Dora Stern. "Lessons from the Impact of Price Regulation on the Pricing of Anticancer Drugs in Germany." Health Affairs 39, no. 7 (July 2020): 1185–1193.